Literature DB >> 20513321

Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico study.

Marc D Breton1, Boris P Kovatchev.   

Abstract

BACKGROUND: Clinical trials assessing the impact of errors in self-monitoring of blood glucose (SMBG) on the quality of glycemic control in diabetes are inherently difficult to execute. Consequently, the objectives of this study were to employ realistic computer simulation based on a validated model of the human metabolic system and to provide potentially valuable information about the relationships among SMBG errors, risk for hypoglycemia, glucose variability, and long-term glycemic control.
METHODS: Sixteen thousand computer simulation trials were conducted using 100 simulated adults with type 1 diabetes. Each simulated subject was used in four simulation experiments aiming to assess the impact of SMBG errors on detection of hypoglycemia (experiment 1), risk for hypoglycemia (experiment 2), glucose variability (experiment 3), and long-term average glucose control, i.e., estimated hemoglobin A1c (HbA1c)(experiment 4). Each experiment was repeated 10 times at each of four increasing levels of SMBG errors: 5, 10, 15, and 20% deviation from the true blood glucose value.
RESULTS: When the permitted SMBG error increased from 0 to 5-10% to 15-20%-the current level allowed by International Organization for Standardization 15197-(1) the probability for missing blood glucose readings of 60 mg/dl increased from 0 to 0-1% to 3.5-10%; (2) the incidence of hypoglycemia, defined as reference blood glucose <or=70 mg/dl, changed from 0 to 0-0% to 0.1-5.5%; (3) glucose variability increased as well, as indicated by control variability grid analysis; and (4) the incidence of hypoglycemia increased from 15.0 to 15.2-18.8% to 22-25.6%. When compensating for this increase, glycemic control deteriorated with HbA1c increasing gradually from 7.00 to 7.01-7.12% to 7.26-7.40%.
CONCLUSIONS: A number of parameters of glycemic control deteriorated substantially with the increase of permitted SMBG errors, as revealed by a series of computer simulations (e.g., in silico) experiments. A threshold effect apparent between 10 and 15% permitted SMBG error for most parameters, except for HbA1c, which appeared to be increasing relatively linearly with increasing SMBG error above 10%. (c) 2010 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513321      PMCID: PMC2901032          DOI: 10.1177/193229681000400309

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  34 in total

1.  Archimedes: a trial-validated model of diabetes.

Authors:  David M Eddy; Leonard Schlessinger
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

2.  Statistical tools to analyze continuous glucose monitor data.

Authors:  William Clarke; Boris Kovatchev
Journal:  Diabetes Technol Ther       Date:  2009-06       Impact factor: 6.118

Review 3.  Lessons from the Diabetes Control and Complications Trial.

Authors:  J V Santiago
Journal:  Diabetes       Date:  1993-11       Impact factor: 9.461

4.  Evaluation of a new blood glucose monitoring system with auto-calibration.

Authors:  Charles Kilo; Mary Pinson; Judy Ostrom Joynes; Hal Joseph; Nanette Monhaut; Joan Lee Parkes; John Baum
Journal:  Diabetes Technol Ther       Date:  2005-04       Impact factor: 6.118

5.  Model predictive control of type 1 diabetes: an in silico trial.

Authors:  Lalo Magni; Davide M Raimondo; Luca Bossi; Chiara Dalla Man; Giuseppe De Nicolao; Boris Kovatchev; Claudio Cobelli
Journal:  J Diabetes Sci Technol       Date:  2007-11

6.  Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus.

Authors:  S A Amiel; W V Tamborlane; D C Simonson; R S Sherwin
Journal:  N Engl J Med       Date:  1987-05-28       Impact factor: 91.245

Review 7.  Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM.

Authors:  P E Cryer
Journal:  Diabetes       Date:  1994-11       Impact factor: 9.461

Review 8.  Self-Monitoring of Blood Glucose (SMBG) in insulin- and non-insulin-using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization, and research.

Authors:  Irl B Hirsch; Bruce W Bode; Belinda P Childs; Kelly L Close; William A Fisher; James R Gavin; Barry H Ginsberg; Charles H Raine; Carol A Verderese
Journal:  Diabetes Technol Ther       Date:  2008-12       Impact factor: 6.118

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

Authors:  N H White; D A Skor; P E Cryer; L A Levandoski; D M Bier; J V Santiago
Journal:  N Engl J Med       Date:  1983-03-03       Impact factor: 91.245

View more
  49 in total

1.  Glucose information for tight glycemic control: different methods with different challenges.

Authors:  Christian Weber; Kurt Neeser
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  We need tighter regulatory standards for blood glucose monitoring, but they should be for accuracy disclosure.

Authors:  Barry H Ginsberg
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

3.  Impact of Glucose Meter Error on Glycemic Variability and Time in Target Range During Glycemic Control After Cardiovascular Surgery.

Authors:  Brad S Karon; Jeffrey W Meeusen; Sandra C Bryant
Journal:  J Diabetes Sci Technol       Date:  2015-08-25

4.  Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 Diabetes in Canada.

Authors:  R Brett McQueen; Marc D Breton; Markus Ott; Helena Koa; Bruce Beamer; Jonathan D Campbell
Journal:  J Diabetes Sci Technol       Date:  2015-08-14

5.  6(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, April 25-27, 2013, Riga, Latvia.

Authors:  Aus Alzaid; Christof Schlaeger; Rolf Hinzmann
Journal:  Diabetes Technol Ther       Date:  2013-09-28       Impact factor: 6.118

6.  Performance and System Validation of a New Cellular-Enabled Blood Glucose Monitoring System Using a New Standard Reference Measurement Procedure of Isotope Dilution UPLC-MRM Mass Spectrometry.

Authors:  Kimon Angelides; Risë K Matsunami; David A Engler
Journal:  J Diabetes Sci Technol       Date:  2015-05-22

7.  Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico Study.

Authors:  Enrique Campos-Náñez; Marc D Breton
Journal:  J Diabetes Sci Technol       Date:  2017-05-31

8.  Clinical Impact of Blood Glucose Monitoring Accuracy: An In-Silico Study.

Authors:  Enrique Campos-Náñez; Kurt Fortwaengler; Marc D Breton
Journal:  J Diabetes Sci Technol       Date:  2017-06-01

Review 9.  Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices.

Authors:  Guido Freckmann; Stefan Pleus; Mike Grady; Steven Setford; Brian Levy
Journal:  J Diabetes Sci Technol       Date:  2018-11-19

10.  The relationships between common measures of glucose meter performance.

Authors:  Daniel R Wilmoth
Journal:  J Diabetes Sci Technol       Date:  2012-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.